1.
Leukemia
; 27(10): 2094-6, 2013 Oct.
Article
in English
| MEDLINE
| ID: mdl-23900138
Subject(s)
Casein Kinase II/antagonists & inhibitors , Hematologic Neoplasms/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Naphthyridines/pharmacology , Receptors, Antigen, B-Cell/antagonists & inhibitors , Signal Transduction/drug effects , Vidarabine/analogs & derivatives , Adenine/analogs & derivatives , Antineoplastic Agents/pharmacology , Casein Kinase II/metabolism , Drug Synergism , Hematologic Neoplasms/metabolism , Humans , Immunoglobulin G/pharmacology , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Phenazines , Piperidines , Prognosis , Purines/pharmacology , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Quinazolinones/pharmacology , Receptors, Antigen, B-Cell/immunology , Receptors, Antigen, B-Cell/metabolism , Vidarabine/pharmacology
2.
Ohio State Med J
; 75(5): 318-9, 1979 May.
Article
in English
| MEDLINE
| ID: mdl-111198